SMI
11.701,72
PKT
-90,19
PKT
-0,76
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.07.12 | Swisscom hold | Vontobel Research | |
29.06.12 | Nestlé sector perform | RBC Capital Markets | |
28.06.12 | Novartis buy | Deutsche Bank AG | |
28.06.12 | UBS neutral | Sarasin Research | |
28.06.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
27.06.12 | UBS overweight | J.P. Morgan Cazenove | |
27.06.12 | Kühne + Nagel International outperform | Credit Suisse Group | |
27.06.12 | Sika buy | Vontobel Research | |
26.06.12 | Swiss Life neutral | Goldman Sachs Group Inc. | |
26.06.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
26.06.12 | UBS outperform | RBC Capital Markets | |
26.06.12 | Kühne + Nagel International buy | Nomura | |
25.06.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
25.06.12 | Holcim neutral | J.P. Morgan Cazenove | |
25.06.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
25.06.12 | Novartis neutral | UBS AG | |
25.06.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
25.06.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
25.06.12 | Novartis buy | UBS AG | |
25.06.12 | UBS kaufen | Die Actien-Börse | |
25.06.12 | Sonova buy | Vontobel Research | |
25.06.12 | UBS hold | Vontobel Research | |
22.06.12 | Richemont overweight | Barclays Capital | |
22.06.12 | Novartis outperform | Credit Suisse Group | |
22.06.12 | Holcim overweight | HSBC | |
22.06.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
22.06.12 | Holcim overweight | HSBC | |
22.06.12 | Swiss Life buy | Deutsche Bank AG | |
22.06.12 | Lonza outperform | Cheuvreux SA | |
22.06.12 | Holcim outperform | Exane-BNP Paribas SA | |
22.06.12 | Holcim hold | Vontobel Research | |
21.06.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
21.06.12 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
20.06.12 | Holcim sell | Citigroup Corp. | |
20.06.12 | Holcim buy | Citigroup Corp. | |
20.06.12 | UBS buy | Citigroup Corp. | |
20.06.12 | Nestlé hold | Vontobel Research | |
19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
18.06.12 | Holcim buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.